Status
Acquired by RetroScreen Virology on March 4, 2014
Funding Received
$805 Thousand in 1 Round from 2 Investors
Headquarters:
London
Description:
Activiomics develops phosphoproteomics solutions for biomarker discovery and drug candidate profiling.
Categories:
Biotechnology
Website:
http://www.activiomics.com

Company Details

Update

Activiomics Ltd. has developed a groundbreaking and patented technology that will enable a transformation in the way in which biomarkers are identified, diagnostics are developed and drug candidates are identified and profiled.

Activiomics' technology centres around novel mass spectrometry based approaches for the global quantitative analysis of phosphorylation sites. Phosphorylation is critical mediator all cellular processes and hence sites of phosphorylation represent an important class of novel biomarkers. Activiomics' TIQUAS (Targeted In-depth QUAntification of cell Signalling) technology enables the quantification of thousands of phosphorylation events from a given tissue sample and the subsequent markers of response that are identified will enable the development of future diagnostics.

Current Team (4)

Update

Funding Rounds (1) - $805k

Update

Investors (2)

Update

Offices/Locations (1)

Update
  • Office

    24 Cornhill

    London, EC3V 3ND

    GBR

Images (1)

Update
  • 7a3b9acb4f97fb0f8f23c747b7613a76